Revvity, Inc. (RVTY) Stock Price

RVTYStock

$124.84+30.64%52W

Market Cap$13.93B

P/E54.27x

PEG Ratio0.74

Div yield0.31%

Beta1.08

RVTY Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)14.60%

Price vs S&P 500 (4W)7.25%

PEG Ratio0.74

VGM Score48.96

P/E Ratio (Annual)54.27x

Indicated Dividend Yield (Annual)0.31%

P/CF (Annual)22.45x

Book Value / Share (Quarterly)$64.76

P/TBV (Annual)2.25x

Indicated Dividend (Annual)$0.28

Revenue Growth (3Y)-4.82%

Cash Flow / Share (Quarterly)$5.00

Payout Ratio (TTM)13.36%

Price vs S&P 500 (YTD)15.17%

Gross Margin (TTM)54.98%

Net Profit Margin (TTM)8.16%

EPS (TTM)$2.10

10-Day Avg Trading Volume1.41M

EPS Excl Extra (TTM)$2.10

Revenue Growth (5Y)-5.46%

EPS (Annual)$2.07

Dividend / Share (Annual)$0.28

ROI (Annual)2.30%

Gross Margin (Annual)54.77%

Net Profit Margin (5Y Avg)17.06%

Cash / Share (Quarterly)$9.16

P/E Basic Excl Extra (TTM)55.10x

Revenue Growth QoQ (YoY)1.31%

EPS Growth (5Y)-20.45%

P/E Normalized (Annual)54.27x

ROA (Last FY)1.98%

Revenue Growth TTM (YoY)4.05%

EBITD / Share (TTM)$6.82

ROE (5Y Avg)7.32%

Operating Margin (TTM)12.32%

Cash Flow / Share (Annual)$4.54

P/B Ratio1.81x

P/B Ratio (Quarterly)1.74x

Net Income / Employee (Annual)$21,900

EV / Revenue (TTM)5.24x

Net Interest Coverage (TTM)4.07x

ROA (TTM)1.97%

EPS Growth QoQ (YoY)1.13%

EV / EBITDA (TTM)19.81x

EPS Incl Extra (Annual)$2.07

Current Ratio (Annual)1.68x

Quick Ratio (Quarterly)1.50x

3-Month Avg Trading Volume1.50M

52-Week Price Return30.64%

EV / Free Cash Flow (Annual)29.98x

P/E Incl Extra (TTM)55.10x

Revenue / Employee (TTM)$264,700

Tangible BV / Share (Quarterly)$44.83

P/S Ratio (Annual)4.58x

Asset Turnover (Annual)0.23x

52-Week High$124.97

Operating Margin (5Y Avg)18.26%

EPS Excl Extra (Annual)$2.07

CapEx CAGR (5Y)-1.05%

26-Week Price Return25.84%

Quick Ratio (Annual)1.40x

13-Week Price Return28.96%

Total Debt / Equity (Annual)0.44x

Current Ratio (Quarterly)1.80x

Enterprise Value$15.27B

Revenue / Share Growth (5Y)-6.21%

Asset Turnover (TTM)0.24x

Book Value / Share Growth (5Y)20.85%

Revenue / Employee (Annual)$259,600

Inventory Turnover (Annual)3.46x

Pretax Margin (Annual)9.39%

Cash / Share (Annual)$8.19

3-Month Return Std Dev37.44%

Gross Margin (5Y Avg)58.05%

Net Income / Employee (TTM)$21,600

EBITDA CAGR (5Y)-9.06%

EBITDA Interim CAGR (5Y)-14.06%

ROE (Last FY)3.33%

Net Interest Coverage (Annual)3.53x

EPS Basic Excl Extra (Annual)$2.07

P/FCF (TTM)23.45x

Receivables Turnover (TTM)4.25x

EV / Free Cash Flow (TTM)27.36x

Total Debt / Equity (Quarterly)0.44x

EPS Incl Extra (TTM)$2.10

Receivables Turnover (Annual)4.15x

ROI (TTM)2.27%

Dividend Growth Rate (5Y)0.08%

P/S Ratio (TTM)4.50x

Pretax Margin (5Y Avg)15.73%

Revenue / Share (Annual)$24.50

Tangible BV / Share (Annual)$43.67

Forward P/E20.29x

Free OCF CAGR (5Y)-8.96%

Price vs S&P 500 (52W)12.33%

P/E Ratio (TTM)55.10x

EPS Growth TTM (YoY)-10.84%

Year-to-Date Return27.13%

5-Day Price Return8.13%

EPS Normalized (Annual)$2.07

ROA (5Y Avg)3.92%

Net Profit Margin (Annual)8.45%

Month-to-Date Return9.31%

Cash Flow / Share (TTM)$5.13

EBITD / Share (Annual)$6.54

EPS Growth (3Y)-22.83%

Operating Margin (Annual)12.49%

LT Debt / Equity (Annual)0.36x

P/CF (TTM)20.85x

ROI (5Y Avg)4.66%

P/E Excl Extra (TTM)55.10x

LT Debt / Equity (Quarterly)0.36x

EPS Basic Excl Extra (TTM)$2.10

P/TBV (Quarterly)2.52x

Payout Ratio (Annual)13.60%

P/B Ratio (Annual)1.52x

Dividend / Share (TTM)$0.28

Inventory Turnover (TTM)3.42x

Pretax Margin (TTM)8.96%

Book Value / Share (Annual)$64.57

Price vs S&P 500 (13W)26.16%

Net Margin Growth (5Y)-15.17%

Dividend Yield (TTM)0.24%

Beta1.08x

P/FCF (Annual)25.69x

Revenue / Share (TTM)$26.08

ROE (TTM)3.27%

52-Week Low$81.22

vGradeC

gGradeD

mGradeB

vgmGradeC

RVTY Earnings Surprise History

Q2 251.18est. 1.14

Q3 251.18est. 1.14

Q4 251.70est. 1.58

Q1 261.06est. 1.01

Q2 261.41est. 1.22

RVTY Analyst Recommendations

May 2026

Jun 2026

Jul 2026

Aug 2026

3.76

3.75

3.72

Industry Peers — Lab Analytical Instruments(26)

Symbol	Value Score	Growth Score	Momentum Score	Price
RVTYRevvity, Inc.	C	D	B	$124.84
AAgilent Technologies Inc.	D	C	B	$154.77
WATWaters Corp	D	C	B	$414.44
ILMNIllumina Inc	D	D	A	$224.99
MTDMettler-Toledo International	D	C	B	$1402.25
BIOBio-Rad Laboratories, Inc.Class A	C	D	B	$390.34
BIO.BBio-Rad Laboratories, Inc. Class B	C	D	B	$365.08
AVTRAvantor, Inc.	B	F	A	$14.42
BRKRBruker Corporation	D	D	B	$56.85
TXG10x Genomics, Inc. Class A Common Stock	F	D	A	$64.72
ALMRAlamar Biosciences, Inc. Common Stock	—	—	A	$33.02
CTKBCytek Biosciences, Inc. Common Stock	C	C	C	$4.58
PACBPacific Biosciences of California, Inc.	D	C	C	$1.52
MASS908 Devices Inc. Common Stock	C	C	A	$11.00
EYPTEyePoint, Inc. Common Stock	D	F	F	$5.00
PREPrenetics Global Limited Class A Ordinary Share	C	D	A	$23.25
LABStandard BioTools Inc. Common Stock	A	F	D	$0.65
QTRXQuanterix Corporation Common Stock	A	C	C	$2.79
SEERSeer, Inc. Class A Common Stock	C	D	C	$2.04
NAUTNautilus Biotechnolgy, Inc. Common Stock	—	—	C	$0.88
RPIDRapid Micro Biosystems, Inc. Class A Common Stock	C	B	D	$1.66
PRPOPrecipio, Inc. Common Stock	C	A	A	$30.85
HBIOHarvard Bioscience Inc	B	F	A	$7.58
ASTCAstrotech Corporation (DE) Common Stock	C	C	A	$7.10
BNGOBionano Genomics, Inc. Common Stock	A	C	C	$1.25
HLTHTema Healthcare AI ETF	—	F	D	$29.92
PRENWPrenetics Global Limited Warrant	—	—	D	$0.01

About Revvity, Inc.

Revvity, formed in 2023 through PerkinElmer's rebranding, is a global life sciences and diagnostics company serving biopharma, academic research, and clinical markets. The company operates two segments: Life Sciences, providing reagents and instruments for research applications, and Diagnostics, delivering immunodiagnostics and newborn and reproductive health solutions. With established operations across North America, Europe, and China, Revvity serves customers worldwide in research and clinical diagnostics.